朱丹溪应用生姜汁的经验浅析OACSTPCD
Brief analysis of Zhu Danxi's experience in using Shengjiangzhi
生姜汁味辛性微温,具有解表散寒、温中止呕、化痰止咳等功效.金元医家朱丹溪善用生姜汁,选方用药往往强调生姜汁的不可替代作用.通过研读丹溪及其弟子的著作,发现丹溪应用生姜汁的特色主要表现在:同诸药内服,借其通阳化气、温通化痰之功效,治疗痰证、血证、痛证等诸多内科疾病疗效显著;作为黏合剂制作丸剂,既顾护脾胃又加强原方的治疗作用;作为炮制辅料,或减毒或增效,扩充了生姜汁炮制药物的种类.丹溪对生姜汁的应用遵古又创新,拓展了生姜汁的适应证范围,有助于深入认识生姜汁药性和功用,为现代临床治疗疾病提供参考,为合理应用生姜汁提供借鉴.
Shengjiangzhi(Succus Rhizomatis Zingiberis),with its pungent and slightly warm taste,possesses various therapeutic effects,including relieving the exterior and dissipating cold,warming the center and arresting vomiting,and resolving phlegm.Renowned physician Zhu Danxi from the Jin and Yuan Dynasties demonstrated expertise in utilizing Shengjiangzhi,highlighting its irreplaceable role in herb selection and creation of formulas.Through a study of his works and those of his disciples,distinct features in his application of Shengjiangzhi emerge.These include its oral administration alongside various medicines,leveraging its abilities to promote yang,transform qi,and warm and resolve phlegm,resulting in remarkable therapeutic efficacy for conditions such as phlegm syndrome,blood syndrome,and pain syndrome.Additionally,Shengjiangzhi serves as an adhesive in pill formulations,offering protection to the spleen and stomach while enhancing the therapeutic effects of the original formula.When employed as a processing ingredient,Shengjiangzhi can reduce toxicity or enhance efficacy,broadening the range of processed drugs.Zhu's application of Shengjiangzhi combines traditional wisdom with innovative approaches,expanding its indications and providing valuable insights for the modern clinical treatment of diseases.This study contributes to a deeper understanding of the medicinal properties and functions of Shengjiangzhi,offering guidance for its rational application in contemporary medical practice.
刘雅芳;曲昌成;林艳巧
浙江中医药大学 杭州 310053黑龙江中医药大学福建省霞浦县医院
中医学
朱丹溪生姜汁临证经验
Zhu DanxiShengjiangzhi(Succus Rhizomatis Zingiberis)clinical experience
《现代中医临床》 2024 (003)
54-57,107 / 5
第五批全国中医临床优秀人才研修项目(No.国中医药人教函[2022]239号)
评论